Publicaciones en colaboración con investigadores/as de Hospital Universitario Príncipe de Asturias (14)

2024

  1. Use of Tirzepatide in Adults with Type 2 Diabetes Mellitus: Scientific Evidence and Practical Aspects

    Diabetes Therapy, Vol. 15, Núm. 7, pp. 1501-1512

2023

  1. Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry

    Nefrologia, Vol. 43, Núm. 4, pp. 442-451

  2. MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 7, pp. 1729-1740

2022

  1. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2020

  1. Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease

    Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024

2019

  1. Association of candidate gene polymorphisms with chronic kidney disease: Results of a case-control analysis in the NEFRONA cohort

    Frontiers in Genetics, Vol. 10, Núm. FEB

2017

  1. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520

2015

  1. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

    Nephrology Dialysis Transplantation, Vol. 30, Núm. 7, pp. 1176-1185

2011

  1. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. the CORES Study

    Nephrology Dialysis Transplantation, Vol. 26, Núm. 6, pp. 1938-1947

  2. H2O2 regulation of vascular function through sGC mRNA stabilization by HuR

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 31, Núm. 3, pp. 567-573

  3. Vascular calcification in patients with chronic kidney disease: Types, clinical impact and pathogenesis

    Medical Principles and Practice, Vol. 20, Núm. 3, pp. 203-212

2010

  1. New therapies: Calcimimetics, phosphate binders and vitamin D receptor activators

    Pediatric Nephrology

2008

  1. Oral active vitamin D is associated with improved survival in hemodialysis patients

    Kidney International, Vol. 74, Núm. 8, pp. 1070-1078

2006

  1. Efficacy of lanreotide Autogel® administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: A phase III trial

    Clinical Endocrinology, Vol. 65, Núm. 3, pp. 320-326